Navigation Links
MDS Analytical Technologies Releases MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 Cellular Imaging Software
Date:4/26/2009

goal."

Another enhancement to MetaXpress(R) 3.0 software is the release of the Micronuclei Application Module that allows users to find, evaluate and quantitate micronuclei in nucleated cells for HCS. This product uses a proprietary algorithm that is a significant improvement over existing competitive micronuclei detection methods. Using additional probes, this new application module makes it possible for users to additionally differentiate between mitotic, apoptotic, and necrotic cells, expanding the toxicology measurement suite significantly.

MDS Analytical Technologies at SBS Conference and Exhibition 2009

MetaXpressPowerCore(TM) and MetaXpress(R) 3.0 software programs are being presented to attendees at the Society for Biomolecular Sciences Conference and Exhibition 2009, which is being held April 26-30, in Lille, France. MDS Analytical Technologies can be found at booth 76.

About MetaXpress(R) Software

The MetaXpress(R) program is based on the MetaMorph(R) software backbone, and is used to power the suite of cellular imaging instruments and analysis software for automated imaging and HCS. MetaXpress(R) software is integrated with a data-management solution, turnkey application modules, and the PowerCore analysis option that increases the flexibility and overall speed of workflow.

About MDS Analytical Technologies

MDS Analytical Technologies, a business unit of MDS Inc., is focused on the research, design, manufacture and marketing of state-of-the-art tools for mass-spectrometry, drug discovery and bioresearch. MDS Analytical Technologies' products are designed to help accelerate the complex process of discovering and developing new drug compounds, and are sold to research scientists around the world. The mass-spectrometer product lines are also sold globally through joint ventures with two of the world's leading analytical instrumentation and life-scie
'/>"/>

SOURCE MDS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection
2. MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food
3. MDS Analytical Technologies Laser Capture Microdissection Helps Facilitate Discovery of Potential New Colon-Cancer Biomarker
4. Polymathic Analytical Labs Launches New Website
5. Patheon Opens New U.S. Headquarters and Analytical Laboratory Facility in Research Triangle Park, NC
6. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
7. Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform
8. MDS Analytical Technologies Acquires Blueshift Biotechnologies
9. Pace Analytical Services, Inc., Purchases Laucks Testing Laboratory, Inc.
10. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago
11. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... frozen plasma are being used inappropriately, states a commentary ... ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj081933.pdf . There ... of red blood cells and platelets but not enough ... "Two recent studies in Canada found that 45% ...
... ... the counter medical products has signed a 6 year deal with international super bantam weight ... in the Philippines , ... -- The company’s flagship product, a lotion called Elmore Oil ( www.elmoreoil.com.au ), ...
... informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel , ... in adults. Furthermore, the authorities in Paraguay and Azerbaijan have approved ... Paraguay and Azerbaijan . , ... ...
... ST. PAUL (March 15, 2010) Researchers at the University ... may, over the long term, protect the hearts of ... common form of muscular dystrophy in children. The chemical, ... seeks out tiny cuts in diseased heart muscle. When ...
... , MISSISSAUGA, ON , March 15 /PRNewswire-FirstCall/ ... company focused on the research and development of drug products ... topical and transdermal drug delivery technologies, and on the development ... it has enrolled the first patient in its European Phase ...
... of Dermatology, researchers report that in the United States, melanoma ... in the population 65 years and older. The incidence of ... have the highest rate of mortality. Epidemiologists say that one in ... lifetime, in contrast to one in 1,500 persons in the 1930s. ...
Cached Medicine News:Health News:Filipino World Champion Endorses Charity to Help Fight Child Poverty 2Health News:Filipino World Champion Endorses Charity to Help Fight Child Poverty 3Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 2Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 3Health News:Yondelis(R) Receives Five New Approvals Outside the European Economic Area 4Health News:Researchers discover chemical that may protect hearts of muscular dystrophy patients 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 3Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 4Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 5Health News:Late-stage melanoma results in economic burden 2
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... To Be Presented at American Association of Immunologists ... 2008 ,Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... may be a useful treatment for type 1 ... American Association,of Immunologists meeting in San Diego, California ...
... DEARBORN, Mich., April 7, 2008 Wayne State,University ... implanted a new device designed to combat congestive ... become a leading tool in,the arsenal to combat ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080407/DC18745 ), The April ...
Cached Medicine Technology:Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model 2Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model 3Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 2Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 3Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: